NSE: MASTEK | BSE: 523704

Mid-range Performer

Download real time

2546.90 8.30 (0.33%)

34.97% Gain from 52W Low

32,929 NSE+BSE Volume

NSE 20 Aug, 2025 3:31 PM (IST)

7,882.6

Market Cap

High in industry

1.3

Beta 1Year

Very High Volatility

Mastek Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MASTEK, BSE:523704 Mastek Ltd.

Search Inside the pdf :

Mastek Ltd.

22 Jul 2025

2546.90

0.33%

Mastek Ltd is a Mumbai-based global provider of digital engineering and cloud transformation services, operating in over 40 countries. It partners with Oracle, Salesforce, Microsoft, AWS, and Snowflake to deliver consulting, data analytics, and enterprise solutions. The UK and Europe contribute 64% of revenue, followed by the US and Middle East. Sector-wise, Government and Education lead with 39%,...

Mastek Ltd. is trading below its 200 day SMA of 2573.3

Mastek Ltd.

22 Jul 2025

2546.90

0.33%

Mastek: Resilient UK, as NA & AMEA drag. Is this the inflection point? Retaining a Buy

Buy: Mastek Ltd.

Target

Anand Rathi

Mastek’s Q1FY26 performance highlights ongoing execution challenges in NA and AMEA, with CC revenue declining -1.1% q/q, reflecting transition issues coupled with Payer and Retail-client-specific concerns in the US.

Mastek Ltd. has an average target of 3207.33 from 3 brokers.

Mastek Ltd.

21 Apr 2025

2546.90

0.33%

Mixed Quarter, UK to drive growth

Buy: Mastek Ltd.

Sharekhan

Reported revenues stood at $104.6 million, up 2.9% q-o-q in constant currency (CC) terms, beating our estimates of 1.8% q-o-q growth in CC driven by core business in UK and Europe.

Mastek Ltd. is trading above its 150 day SMA of 2403.6

Mastek Ltd.

21 Mar 2025

2546.90

0.33%

Growth momentum to continue amid merger challenges

Buy: Mastek Ltd.

Sharekhan

We participated in a conference call organised by Mastek’s management to address the concerns stemming from the abolishment of NHS England on account of its merger with the Department of Health and Social Care (DHSC).

Mastek Ltd. has an average target of 3207.33 from 3 brokers.

Mastek Ltd.

27 Feb 2025

2546.90

0.33%

UK business on strong footing

Buy: Mastek Ltd.

Target

Sharekhan

Mastek has secured ~$85 million in multiple contracts from a UK public service department to boost Digital, Data and Technology services spread over two years. The company had earlier won a $40 million government services deal during the quarter.

Mastek Ltd. is trading above its 150 day SMA of 2403.6

Mastek Ltd.

17 Jan 2025

2546.90

0.33%

Mixed Quarter, outlook positive

Buy: Mastek Ltd.

Sharekhan

Mastek reported revenues of $102.9 million, up 0.1% q-o-q/7.6% y-o-y in constant currency (CC), missing our estimates of $104.8 million. Revenue in $ terms was down 0.7%q-o-q/up 9.4% y-o-y while revenue in rupee terms stood at Rs 869.5 crore, up 0.2% q-o-q/10.9% y-o-y.

Mastek Ltd. is trading below its 200 day SMA of 2573.3

Mastek Ltd.

18 Oct 2024

2546.90

0.33%

Solid Q2; Maintain Buy

Buy: Mastek Ltd.

Target

Sharekhan

Reported revenues stood at $103.6 million, up 4.7% q-o-q/10.2% y-o-y in constant currency (CC) terms, beating our estimates of $101.5 million.

Mastek Ltd. is trading below its 200 day SMA of 2573.3

Mastek Ltd.

19 Jul 2024, 12:00AM

2546.90

0.33%

Decent Q1; Maintain Buy

Buy: Mastek Ltd.

Sharekhan

Mastek reported revenues of $97.3 million, up 4.1% q-o-q/9.9% y-o-y in constant currency terms, beating our estimates of $95 million.

Mastek Ltd. has an average target of 3207.33 from 3 brokers.

Mastek Ltd.

29 Apr 2024

2546.90

0.33%

Muted Quarter; Confident commentary

Buy: Mastek Ltd.

Target

Sharekhan

Mastek’s reported revenue stood at $93.7 million, down 1.4% q-o-q/up 6% y-o-y in constant currency (CC) terms, which was lower than our estimate of $96.3 million on account of three specific client situations.